Cellectar Biosciences, Inc. (CLRB)
NASDAQ: CLRB · Real-Time Price · USD
0.311
-0.023 (-6.88%)
At close: Feb 21, 2025, 4:00 PM
0.304
-0.007 (-2.38%)
After-hours: Feb 21, 2025, 7:30 PM EST
Cellectar Biosciences Employees
Cellectar Biosciences had 20 employees as of December 31, 2023. The number of employees increased by 5 or 33.33% compared to the previous year.
Employees
20
Change (1Y)
5
Growth (1Y)
33.33%
Revenue / Employee
n/a
Profits / Employee
-$2,505,360
Market Cap
14.35M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 440,000 |
Johnson & Johnson | 131,900 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 72,000 |
CLRB News
- 17 days ago - Cellectar Biosciences to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 5 weeks ago - Cellectar Biosciences to Highlight 2025 Strategic Initiatives at Upcoming Biotech Showcase during the JP Morgan Healthcare Conference - GlobeNewsWire
- 2 months ago - Cellectar Biosciences Stock Plunges As Cancer-Focused Cancer Firm Pursues Strategic Options - Benzinga
- 2 months ago - Cellectar Biosciences Provides Strategic Update on Clinical Development, Pipeline Programs and Corporate Restructuring - GlobeNewsWire
- 3 months ago - NorthStar Medical Radioisotopes Executes Supply Agreement With Cellectar Biosciences for Therapeutic Radioisotope Actinium-225 (Ac-225) - Business Wire
- 3 months ago - Cellectar Biosciences, Inc. (CLRB) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Cellectar Biosciences Reports Financial Results for Q3 2024 and Provides a Corporate Update - GlobeNewsWire
- 3 months ago - Cellectar Biosciences and NorthStar Medical Radioisotopes Announce Partnership for Supply of Actinium-225 - GlobeNewsWire